CDKL5 deficiency disorder – Basic Information

Go back

CDKL5 deficiency disorder is a rare genetic condition that brings profound challenges from the very start of life, marked by early seizures and significant developmental delays that affect every aspect of a child’s growth and daily functioning.

Understanding CDKL5 Deficiency Disorder

CDKL5 deficiency disorder is a complex genetic condition that dramatically affects brain development and function. This disorder begins to show its effects in the earliest weeks and months of a baby’s life, bringing challenges that families must learn to navigate together. The name comes from the CDKL5 gene, which stands for cyclin-dependent kinase-like 5, a gene that was first identified in 2004 and was previously known as STK9.[1]

The condition was once thought to be a variant of Rett syndrome because the two disorders share some similar features, including seizures and developmental difficulties. However, researchers have now established that CDKL5 deficiency disorder is its own distinct condition with unique characteristics and a different genetic cause. In fact, studies have shown that less than a quarter of people with CDKL5 deficiency disorder actually meet the clinical criteria for early onset Rett syndrome.[2]

This disorder is now recognized as one of the most common forms of genetic epilepsy, even though it is still considered rare overall. It represents a developmental and epileptic encephalopathy, which means it is a condition where both the underlying brain dysfunction and the seizures themselves contribute to developmental delays and intellectual disability.[3]

Epidemiology: How Common Is CDKL5 Deficiency Disorder

CDKL5 deficiency disorder is a rare condition, but it is more common than many other genetic disorders affecting the brain. The occurrence is estimated to be approximately 1 in 40,000 to 60,000 live births. This makes it one of the more frequently encountered forms of genetic epilepsy, though families may still feel isolated because of its rarity.[1][4]

The gender distribution of this disorder is notably uneven. About 90 percent of those diagnosed with CDKL5 deficiency disorder are girls, while only about 10 percent are boys. This pattern occurs because the CDKL5 gene is located on the X chromosome, one of the two sex chromosomes that determine biological sex.[1]

Since females have two X chromosomes and males have only one X chromosome (along with one Y chromosome), the genetic inheritance pattern affects the two sexes differently. Girls can be affected when they have a problem with one of their two X chromosomes, while boys are affected when their single X chromosome carries the genetic variant. However, the severity of symptoms can be similar in both males and females who have the disorder. The severity can vary depending on several factors, including the specific type of genetic change present, the pattern of X-chromosome inactivation in females, and whether the genetic change occurred in all cells or only some cells of the body.[3]

CDKL5 deficiency disorder has been identified in children around the world, across different ethnic and racial groups. As awareness of the condition grows among doctors and genetic testing becomes more widely available, more cases are being identified. Researchers believe there are likely many people with milder forms of CDKL5 deficiency disorder who have not yet been diagnosed, particularly those who may have some symptoms but not the severe early-onset seizures that typically lead to genetic testing.[4]

Causes of CDKL5 Deficiency Disorder

CDKL5 deficiency disorder is caused by changes (called variants or mutations) in the CDKL5 gene. This gene provides essential instructions for making a protein that plays a crucial role in brain and neuron development. The CDKL5 protein functions as a kinase, which is a type of enzyme that modifies other proteins by adding phosphate groups to them at specific locations. This process of adding phosphate groups helps control the activity of other proteins in brain cells.[1][4]

When there are variants in the CDKL5 gene, the body either produces less of the CDKL5 protein than normal or creates a version of the protein that does not work properly. Scientists have not yet fully determined which specific proteins are targeted by the CDKL5 protein, but they know that when there is a shortage or impairment of CDKL5 protein function in nerve cells (neurons), brain development is disrupted. This disruption leads to the seizures, developmental delays, and other features seen in people with the disorder.[1]

The types of genetic changes that can cause CDKL5 deficiency disorder are varied. Some are missense variants, which are like spelling errors in the DNA code that cause one building block (amino acid) to be substituted for another in the protein. Others are truncations or deletions, which result in a shortened version of the protein or a missing piece of the gene that can prevent the protein from being made at all. More than 250 different mutations in the CDKL5 gene have been identified so far, and researchers continue to discover new ones.[2][7]

⚠️ Important
The genetic mutation that causes CDKL5 deficiency disorder is usually “de novo,” meaning it is a new mutation that occurs spontaneously in the child’s genes. It is not passed down from the parents in most cases. Parents who have a child with this disorder did not do anything during pregnancy to cause it, and they could not have done anything to prevent it. The mutation typically happens randomly during the formation of egg or sperm cells, or very early in embryo development.[7][15]

Although most cases occur spontaneously, there have been rare instances where multiple siblings in the same family have been affected by the same genetic variant. In such cases, one parent may carry the mutation in some but not all of their cells (a condition called mosaicism), or the mutation may be present in their reproductive cells without affecting their own health.[6]

Risk Factors

Because CDKL5 deficiency disorder is caused by spontaneous genetic mutations that occur randomly, there are no known behavioral, environmental, or lifestyle risk factors that increase the likelihood of a child being born with the condition. Parents cannot do anything to increase or decrease the risk, as the genetic changes typically happen by chance during the formation of reproductive cells or early embryonic development.[15]

The location of the CDKL5 gene on the X chromosome does create a pattern where females are more commonly affected than males, with a female-to-male ratio of approximately 4 to 1. However, this is not a risk factor that can be modified; it is simply a consequence of how sex chromosomes are inherited.[3]

Advanced parental age has been associated with increased rates of new genetic mutations in some conditions, but there is no specific evidence linking parental age to CDKL5 deficiency disorder. Similarly, there are no known ethnic, racial, or geographic risk factors that make certain populations more susceptible to the disorder. It appears to occur with similar frequency across different populations around the world.[4]

For families who already have one child with CDKL5 deficiency disorder, the risk of having another affected child is generally very low, since most cases are caused by new mutations. However, genetic counseling can be helpful for families to understand their specific situation, especially in the rare cases where a parent might have mosaicism or carry the mutation in their reproductive cells.[6]

Symptoms and Clinical Features

The symptoms of CDKL5 deficiency disorder can vary considerably from one child to another, but certain features are common to most cases. The hallmark symptom is early-onset seizures, which typically begin before the child is three months old. In fact, about 90 percent of children with CDKL5 deficiency disorder develop seizures before three months of age, and some begin having seizures as early as the first week after birth. The median age for seizure onset is around five weeks.[2][9]

The seizures in CDKL5 deficiency disorder can take many different forms. The most common types include generalized tonic-clonic seizures, which involve a loss of consciousness, muscle rigidity throughout the body, and convulsions. Children may also experience tonic seizures, characterized by abnormal muscle contractions and stiffening, and epileptic spasms, which involve short episodes of muscle jerks. Another common pattern is infantile spasms, which often appear as a bending of the body and straightening of the limbs, lasting only one or two seconds but occurring in clusters.[1][7]

Children with CDKL5 deficiency disorder may also have seizures with multiple distinct phases, such as a sequence that includes hypermotor movements, tonic stiffening, and spasms. The types of seizures can change as the child grows older, often following a predictable pattern. Unfortunately, seizures in this disorder are typically very difficult to control with medications. Most affected individuals have seizures daily, although they may experience periods when they are temporarily seizure-free. Prolonged seizures lasting longer than five minutes (status epilepticus) can also occur.[1][2][7]

Beyond seizures, children with CDKL5 deficiency disorder face significant developmental challenges. Most have severe intellectual disability and little or no speech. Many children struggle to develop language and communication skills, though some learn to use complex gestures or vocalizations to express themselves. Social skills are also affected, and some children show features that overlap with autism spectrum disorder, though many do not meet the formal criteria for autism.[1][2]

Motor development is typically delayed or severely impaired. The development of gross motor skills, such as sitting, standing, and walking, is significantly delayed, and many children never achieve these milestones. About one-third of affected individuals are able to walk independently, while the majority require assistance or use wheelchairs for mobility. Fine motor skills, such as grasping objects or picking up small items with the fingers, are also impaired. Approximately half of affected individuals develop purposeful use of their hands.[1][2]

Most children with CDKL5 deficiency disorder have low muscle tone (hypotonia), which contributes to their difficulties with movement and development. However, over time, some children develop increased muscle tone in their legs, making muscles stiff rather than floppy. This change in muscle tone can lead to additional complications.[2]

Vision problems are very common. Many children have cortical visual impairment, which means they have difficulty interpreting what they see because of problems with how the brain processes visual information, even though the eyes themselves are structurally normal. These children may have poor eye contact and difficulty fixing their gaze on objects.[1][2]

Sleep disturbances affect many children with CDKL5 deficiency disorder. They may have trouble falling asleep, wake frequently during the night, or have a lot of energy at nighttime. These sleep problems can be exhausting for both the child and their caregivers, particularly since seizures often occur during sleep as well.[2][15]

Feeding difficulties and gastrointestinal problems are common challenges. Many children have trouble with swallowing and chewing because of weakness in the muscles responsible for these functions. This can increase the risk of aspiration, which occurs when food, liquids, or saliva enter the airway instead of going down to the stomach. Gastrointestinal issues include constipation, gastroesophageal reflux (backflow of acidic stomach contents into the esophagus), diarrhea, and intestinal gas. Many children require a feeding tube to ensure they receive adequate nutrition.[1][2][15]

Growth restriction is common, with many children being smaller than expected for their age. Orthopedic complications can develop due to low muscle tone, including scoliosis (side-to-side curvature of the spine) and hip dysplasia (abnormal development of the hip joint).[1][2]

Some children have repetitive, purposeless movements of the hands, known as stereotypies. These can include hand clapping, hand licking, or hand sucking. Other movement disorders may also occur. Additional features that may be present include teeth grinding (bruxism), irregular breathing patterns (such as periods of very fast or very slow breathing), episodes of unexplained laughing or screaming, and cold hands and feet.[1][2]

A small number of children have distinctive facial features, though these are subtle and not always present. These features can include a high and broad forehead, large and deep-set eyes, a well-defined space between the nose and upper lip (philtrum), full lips, widely spaced teeth, and a high roof of the mouth (palate). Some children have an unusually small head size (microcephaly) and tapered fingers.[1][2]

Prevention

Because CDKL5 deficiency disorder is caused by spontaneous genetic mutations that occur randomly and are not influenced by parental behavior or environmental factors, there are currently no known prevention strategies. Parents cannot take any actions before or during pregnancy to prevent the genetic changes that cause this disorder. The mutations typically arise as new events during the formation of egg or sperm cells or in early embryonic development, making them impossible to predict or prevent with current medical knowledge.[15]

However, early recognition and diagnosis of the condition can be considered a form of secondary prevention, as it allows families to access appropriate care and support services as soon as possible. When parents notice unusual movements or behaviors in their infant, such as stiffening, turning red in the face, throwing the arms out, or holding the breath until the lips turn blue, they should seek medical attention promptly. Early identification of seizures and other symptoms can lead to earlier genetic testing and diagnosis.[19]

For families who already have a child with CDKL5 deficiency disorder, genetic counseling can provide valuable information about the risk of recurrence in future pregnancies. In most cases, the risk is very low because the mutation occurred spontaneously. However, genetic counselors can assess whether either parent has mosaicism (the mutation present in some but not all of their cells) or carries the mutation in their reproductive cells, which could slightly increase the risk for future children.[6]

Prenatal testing options may be available for families at increased risk, though these situations are rare. Genetic counselors can discuss the options, benefits, and limitations of prenatal testing with families who are concerned about recurrence.[6]

Pathophysiology: How CDKL5 Deficiency Affects the Body

The pathophysiology of CDKL5 deficiency disorder involves complex changes in how the brain develops and functions. At the cellular level, the disorder begins with problems in the CDKL5 protein, which is a serine-threonine kinase enzyme involved in neural maturation and the formation of connections between brain cells (synaptogenesis).[8]

The CDKL5 protein normally works by adding phosphate groups to other proteins in neurons, which changes their activity and helps regulate various cellular processes necessary for proper brain development. When genetic variants reduce the amount of functional CDKL5 protein or alter its activity, these normal regulatory processes are disrupted. The specific proteins that are targeted by CDKL5 have not been completely identified, but researchers know that the loss or impairment of CDKL5 function interferes with critical developmental processes in brain cells.[1][4]

Without adequate CDKL5 protein function, neurons do not develop properly, and the connections between neurons are not formed or maintained correctly. This disruption in brain development and neural connectivity leads to the seizures and developmental delays that characterize the disorder. The abnormal electrical activity in the brain that causes seizures may result from imbalances in the excitatory and inhibitory signals between neurons, though the exact mechanisms are still being studied.[1]

The seizures themselves can contribute to further developmental problems. The frequent and difficult-to-control seizures interfere with normal brain development during critical early periods of life. This is why CDKL5 deficiency disorder is classified as a developmental and epileptic encephalopathy: both the underlying genetic problem and the seizures it causes work together to impair brain function and development.[7]

The severity of the disorder can vary depending on several factors. The specific type and location of the genetic variant within the CDKL5 gene can influence how much the protein’s function is impaired. In females, who have two X chromosomes, the pattern of X-chromosome inactivation (a normal process where one X chromosome in each cell is randomly turned off) can affect severity. If more cells happen to inactivate the normal X chromosome and keep the mutated one active, symptoms may be more severe.[3]

In some cases, individuals have postzygotic mosaicism, which means the genetic mutation is present in only some of their body’s cells rather than all of them. When this occurs, the individual may have milder manifestations of the disorder because some cells still produce normal CDKL5 protein.[3]

The effects of CDKL5 deficiency extend beyond the brain to affect other body systems. The low muscle tone (hypotonia) that most affected children experience results from problems with how the nervous system controls muscles. The vision problems occur because the visual processing areas of the brain do not develop or function normally. Gastrointestinal problems may relate to poor nerve control of the digestive system muscles. Sleep disturbances likely result from abnormalities in the brain regions that regulate sleep-wake cycles.[1][2]

Ongoing Clinical Trials on CDKL5 deficiency disorder

  • Study on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Germany Ireland Italy The Netherlands +2
  • Study on Long-Term Safety of Soticlestat for Adults and Children with Developmental Epileptic Encephalopathies

    Not recruiting

    1 1
    Investigated drugs:
    Poland Portugal Spain

References

https://medlineplus.gov/genetics/condition/cdkl5-deficiency-disorder/

https://www.childrenshospital.org/conditions/cdkl5-disorder

https://www.ncbi.nlm.nih.gov/books/NBK602610/

https://www.cdkl5.com/about-cdkl5

https://www.childrenscolorado.org/conditions-and-advice/conditions-and-symptoms/conditions/cdkl5-deficiency-disorder/

https://www.chop.edu/conditions-diseases/cdkl5-deficiency-disorder

https://www.childneurologyfoundation.org/disorder/cdkl5-deficiency-disorder/

https://pmc.ncbi.nlm.nih.gov/articles/PMC10801578/

https://jneurodevdisorders.biomedcentral.com/articles/10.1186/s11689-021-09384-z

https://www.cdkl5.com/about-cdkl5

https://www.childrenscolorado.org/conditions-and-advice/conditions-and-symptoms/conditions/cdkl5-deficiency-disorder/

https://www.childrenshospital.org/conditions/cdkl5-disorder

https://pmc.ncbi.nlm.nih.gov/articles/PMC11145618/

https://my.clevelandclinic.org/pediatrics/services/cdkl5-deficiency-disorder-treatment

https://www.cdkl5.com/guide/living-with-cdkl5

https://www.childrenscolorado.org/conditions-and-advice/conditions-and-symptoms/conditions/cdkl5-deficiency-disorder/

https://my.clevelandclinic.org/pediatrics/services/cdkl5-deficiency-disorder-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC11145618/

https://www.chop.edu/stories/cdkl5-deficiency-disorder-averys-story

https://www.childneurologyfoundation.org/disorder/cdkl5-deficiency-disorder/

https://www.cdkl5.com/guide/finding-your-new-normal

https://www.childrenshospital.org/conditions/cdkl5-disorder

FAQ

How is CDKL5 deficiency disorder diagnosed?

Diagnosis is initially suspected based on symptoms, medical history, and physical examination, particularly when a baby has early-onset seizures and developmental delays. Confirmation requires genetic testing, which is a simple blood test that looks for variants in the CDKL5 gene. Most children will already be under the care of a neurologist, geneticist, or other specialist when genetic testing is ordered.[4][10]

Are there any approved treatments for CDKL5 deficiency disorder?

Yes, there is one FDA-approved medication specifically for seizures associated with CDKL5 deficiency disorder. Ganaxolone (brand name Ztalmy) was approved in March 2022 for the treatment of seizures in patients with CDKL5 deficiency disorder who are two years of age and older. This was the first and only approved treatment specifically for this condition. Other anti-seizure medications, ketogenic diet, and various supportive therapies are also used to manage symptoms.[4][10]

Will my child with CDKL5 deficiency disorder be able to walk or talk?

The abilities vary significantly from child to child. About one-third of individuals with CDKL5 deficiency disorder are able to walk independently, while others may require assistance or use wheelchairs. Most children have little or no speech, but approximately half develop purposeful use of their hands and some learn to communicate using complex gestures or vocalizations. Early therapeutic intervention can be helpful, and it’s important not to set limits before knowing what your individual child will accomplish.[1][15]

Did I do something during pregnancy to cause my child’s CDKL5 deficiency disorder?

No. CDKL5 deficiency disorder is caused by spontaneous genetic mutations that occur randomly and are not caused by anything parents did or did not do during pregnancy. The mutation typically happens during the formation of egg or sperm cells or very early in embryo development. Parents could not have done anything to prevent it.[15]

What is the life expectancy for someone with CDKL5 deficiency disorder?

CDKL5 deficiency disorder is a complex medical condition that affects multiple body systems, but it is not immediately life-threatening. While the condition is lifelong and there is currently no cure, affected individuals can live for many years with appropriate medical care and symptom management. Each child’s situation is unique, and life expectancy depends on many factors, including the severity of seizures, respiratory health, and access to quality medical care.[15]

🎯 Key takeaways

  • CDKL5 deficiency disorder is one of the most common forms of genetic epilepsy, occurring in approximately 1 in 40,000 to 60,000 births, yet it remains rare enough that families may feel isolated.
  • Seizures typically begin remarkably early—90% of affected children start having seizures before 3 months of age, with some experiencing them in their first week of life.
  • The disorder affects girls about four times more often than boys because the CDKL5 gene is located on the X chromosome, though severity can be equal in affected males and females.
  • Ganaxolone (Ztalmy) became the first FDA-approved medication specifically for treating seizures associated with CDKL5 deficiency disorder in March 2022, representing a major milestone for affected families.
  • Most genetic mutations causing CDKL5 deficiency disorder occur spontaneously and are not inherited from parents, meaning families could not have prevented the condition.
  • Scientists have identified more than 250 different mutations in the CDKL5 gene that can cause the disorder, and new ones continue to be discovered, highlighting the genetic complexity of this condition.
  • CDKL5 deficiency disorder was once classified as a variant of Rett syndrome, but is now recognized as its own distinct condition with unique features and challenges.
  • The full spectrum of CDKL5 disorders may be broader than currently known—there are likely people with milder symptoms and no seizures who have not yet been diagnosed or identified.